Robert S. Rosenson

Mount Sinai Hospital — United States

Medicine · Health Sciences

79h-index26.7kcitations621works14.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lipoproteins and Cardiovascular Health(379), Diabetes, Cardiovascular Risks, and Lipoproteins(154), Cancer, Lipids, and Metabolism(90), Health Systems, Economic Evaluations, Quality of Life(71), Lipid metabolism and disorders(71)

Publications619 total

GOULD EDU
JACC Advances·2025Open Access
Arteriopathic Effects of Hypertension by Signal Intensity Gradient from Time-of-Flight Magnetic Resonance Angiography
Clinical Neuroradiology·2025
Abstract 4339766: Efficacy of Olpasiran by Apolipoprotein(a) Isoform Size: Insights from the OCEAN(a)-DOSE Trial
Circulation·2025
Abstract 4369532: Estimated absolute coronary heart disease risk reduction with Lp(a) lowering among adults with atherosclerotic cardiovascular disease
Circulation·2025
High lipoprotein(a) is associated with elevated arachidonic acid levels
American Journal of Preventive Cardiology·2025Open Access
Angiopathic Impact of Hypertension and Comorbidities in Healthy Individuals Revealed by Signal Intensity Gradient from TOF-MRA
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2025
EFFECT OF PLOZASIRAN TARGETING APOC3 ON LIPOPROTEIN PARTICLE NUMBER AND SIZE MEASURED BY NMR IN PATIENTS WITH HYPERTRIGLYCERIDEMIA (HTG)
American Journal of Preventive Cardiology·2025Open Access
Association of carotid artery stenosis with cerebral artery signal intensity gradient on time-of-flight magnetic resonance angiography
Frontiers in Neurology·2025· 2 citedOpen Access
Efficacy of evinacumab in patients with severe hypertriglyceridemia and a history of severe hypertriglyceridemia-related acute pancreatitis: A phase 2b trial
Journal of clinical lipidology·2025· 5 citedOpen Access
Gene therapy and genome editing for lipoprotein disorders
European Heart Journal·2025· 14 citedOpen Access
Lipid-Lowering RNA Therapeutics for Atherosclerotic Cardiovascular Disease Prevention: A State−of−the−Art Review
BioDrugs·2025· 4 cited
Metabolic syndrome adversely impacts mortality from steatotic liver disease
European Journal of Preventive Cardiology·2025Open Access
Long-term safety and effectiveness of evinacumab in people with homozygous familial hypercholesterolemia: a plain language summary
Future Cardiology·2025· 1 citedOpen Access
Lipoprotein X – Pathophysiology, diagnosis, and management
Journal of clinical lipidology·2025· 2 cited
Lipoprotein (a) integrates monocyte-mediated thrombosis and inflammation in atherosclerotic cardiovascular disease
Journal of Lipid Research·2025· 7 citedOpen Access
† Effect of plozasiran targeting APOC3 on lipoprotein particle number and size measured by NMR in patients with hypertriglyceridemia
Journal of clinical lipidology·2025
Target Populations for Novel Triglyceride-Lowering Therapies
Journal of the American College of Cardiology·2025· 25 cited
LpX and LpZ associated hypercholesterolemia in a patient with primary sclerosing cholangitis – A case report
Journal of clinical lipidology·2025· 1 cited
LIPOPROTEIN (A) AND CORONARY ATHEROSCLEROSIS IN INTRACORONARY IMAGING - THE YELLOW - LP(A) STUDY
Journal of the American College of Cardiology·2025· 1 citedOpen Access
Effect of Targeting ApoC-III With Plozasiran on Lipoprotein Particle Size and Number in Hypertriglyceridemia
Journal of the American College of Cardiology·2025· 10 cited
page 1 of 31Next →

Frequent Co-authors

Daniel Gaudet(8), M. John Chapman(7), Christie M. Ballantyne(6), Debabrata Mukherjee(6), H. Bryan Brewer(5), Philip J. Barter(5), Sanjay Kaul(5), Deepak L. Bhatt(5), Deborah J. Wesley(5), Anatol Kontush(4), John J.P. Kastelein(4), Gerald F. Watts(4), James D. Otvos(4), Robert A. Harrington(4), Charles R. Bridges(4), Mark J. Eisenberg(4), Victor A. Ferrari(4), Mark A. Hlatky(4), James H. Stein(4), Paul Muntner(4)